Diagnosis and management of malignant hypertension.
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006974:Hypertension, Malignant / Q000175:diagnosis / Q000188:drug therapy*; D007677:Kidney Function Tests; D008297:Male; D008750:Methyldopa / Q000627:therapeutic use; D008914:Minoxidil / Q000627:therapeutic use; D009599:Nitroprusside / Q000627:therapeutic use; D010646:Phentolamine / Q000627:therapeutic use; D011224:Prazosin / Q000627:therapeutic use; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy; D011433:Propranolol / Q000627:therapeutic use; D012110:Reserpine / Q000627:therapeutic use; D012166:Retinal Hemorrhage / Q000209:etiology; D012171:Retinal Vessels; D014294:Trimethaphan / Q000627:therapeutic use
D000959:Antihypertensive Agents; D009599:Nitroprusside; D006830:Hydralazine; D008750:Methyldopa; D008914:Minoxidil; D014294:Trimethaphan; D012110:Reserpine; D011433:Propranolol; D011224:Prazosin; D010646:Phentolamine